$RCUS
Arcus Biosciences, Inc.
XNYS•Health Care•Pharmaceutical Preparations
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateArcus Biosciences, Inc.
XNYS•Health Care•Pharmaceutical Preparations
Why is RCUS down today? It is at $24.34 (-6.92%), and our scanner flagged it 84 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RCUS spikes, and full due diligence on RCUS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RCUS 84 times in the last 30 days. Create a free account to track $RCUS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RCUS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RCUS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystArcus Biosciences, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 24, 2026 · 18 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Azoy Alexander Officer | Sold (automatic/other) | -3K | sold 6.7% | 40K | $85K at $30.00 | Aug 21, 26 |
Azoy Alexander Officer | Other | 3K | added 7.1% | 42K | $44K at $15.44 | Aug 21, 26 |
Jaen Juan C. Officer | Sold (automatic/other) | -20K 0.02% of company | sold 2.4% | 822K | $574K at $28.61 | Jul 10, 26 |
Jaen Juan C. Officer | Sold (automatic/other) | -49K 0.04% of company | sold 5.4% | 842K | $1.5M at $30.05 | Jul 9, 26 |
Jaen Juan C. Officer | Sold (automatic/other) | -6K | sold 0.7% | 891K | $191K at $29.66 | Jun 24, 26 |
Jaen Juan C. Officer | Sold (automatic/other) | -16K 0.01% of company | sold 1.7% | 897K | $437K at $27.69 | Jun 23, 26 |
Jaen Juan C. Officer | Sold (automatic/other) | -9K | sold 1.0% | 913K | $250K at $27.03 | Jun 22, 26 |
Perlman Andrew J Director | Acquired (grant/award) | +6K | added 13% | 48K | n/a | Jun 11, 26 |
Ribas Antoni Director | Acquired (grant/award) | +6K | added 15% | 44K | n/a | Jun 11, 26 |
Falberg Kathryn E Director | Acquired (grant/award) | +6K | added 15% | 44K | n/a | Jun 11, 26 |
Lacey David L. Director | Acquired (grant/award) | +6K | added 8.0% | 77K | n/a | Jun 11, 26 |
Tang Carolyn C. Officer | Other | 34K 0.03% of company | added 23% | 185K | $88K at $2.57 | Jun 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.



Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RCUS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RCUS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RCUS last traded at $24.34, down 6.92% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Arcus Biosciences, Inc. (RCUS) is next expected to report earnings on Tuesday, October 27, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RCUS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RCUS 84 times in the last 30 days.
RCUS (Arcus Biosciences, Inc.) trades on XNYS, with a market cap of about $3.63B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RCUS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RCUS discussion
Sign in to ask a question or join the discussion.